misonidazole has been researched along with Local Neoplasm Recurrence in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (52.17) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Brenner, AJ; Clarke, GD; Floyd, JR; Fox, PT; Huang, S; Hyun, H; Jerabek, PA; Lee, EQ; Michalek, JE; Muzi, M; Reardon, DA; Schmainda, KM; Wen, PY | 1 |
| Ito, YM; Kuge, Y; Nishikawa, Y; Okamoto, S; Onimaru, R; Peng, H; Shiga, T; Shirato, H; Takeuchi, W; Tamaki, N; Tsuchiya, K; Watanabe, S; Yasuda, K | 1 |
| Asaka, T; Hirata, K; Kitagawa, Y; Ohga, N; Sato, J; Satoh, A; Shiga, T; Tamaki, N; Watanabe, S | 1 |
| Baumann, M; Bergmann, R; Beuthien-Baumann, B; Brüchner, K; Hessel, F; Kotzerke, J; Krause, M; Mosch, B; Schütze, C; Steinbach, J; Thames, H; Yaromina, A; Zips, D | 1 |
| Chen, YL; Cheney, MD; DeLaney, TF; Depauw, N; Grosu, AL; Hornicek, FJ; Lim, R; Schwab, JH; Shih, HA; Trofimov, AV; Winrich, BK | 1 |
| Galoforo, S; Grills, IS; Kane, JL; Krueger, SA; Marples, B; Wilson, GD; Wobb, J | 1 |
| Hirata, K; Houkin, K; Ishi, Y; Kobayashi, H; Kobayashi, K; Motegi, H; Shiga, T; Tamaki, N; Terasaka, S; Toyonaga, T; Yamaguchi, S | 1 |
| Clemenceau, S; Ferrand, R; Feuvret, L; George, B; Habrand, JL; Kerrou, K; Lot, G; Mammar, H; Mazure, N; Mokhtari, K; Nataf, V; Polivka, M; Pontvert, D; Pouysségur, J; Talbot, JN | 1 |
| Bares, R; Dittmann, H; Eschmann, SM; Machulla, HJ; Paulsen, F; Reimold, M; Reischl, G; Welz, S | 1 |
| Hicks, RJ; Toner, GC | 1 |
| Ballon, SC; Coleman, CN; Halsey, J; Hirst, VK; Howes, AE; Martinez, A | 1 |
| Battit, GE; Kaufman, SD; Nardi, GL; Orlow, EL; Shipley, WU; Tepper, JE; Warshaw, AL; Wood, WC | 1 |
| Bamberg, M; Scherer, E; Streffer, C; Tamulevicius, P | 2 |
| Fazekas, JT; Goodman, RL; McLean, CJ | 1 |
| Abdelaal, AS; Clarke, BM; Wheldon, TE | 1 |
| Anderson, LL; Donohue, KA; Heller, PB; Hernandez, E; Stehman, FB | 1 |
| Abdelaal, AS; Nias, AH | 1 |
| Hammond, A; Sealy, R; Welsh, D | 1 |
| Fulton, DS; McKinnon, S; Tanasichuk, H; Urtasun, RC | 1 |
| Barry, L; Blekkenhorst, G; Cridland, S; Rombouts, T; Sealy, R | 1 |
| Barthelme, E; Chaplain, G; Chenal, C; Devilhena, M; Horiot, JC; Leonor, J; Raposo, S; Schraub, S; van den Bogaert, W; van der Schueren, E | 1 |
| Edwards, MS; Levin, VA; Liu, HC; Wallner, KE; Wara, WM | 1 |
1 review(s) available for misonidazole and Local Neoplasm Recurrence
| Article | Year |
|---|---|
PET for sarcomas other than gastrointestinal stromal tumors.
Topics: Biopsy; Dideoxynucleosides; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Misonidazole; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2008 |
6 trial(s) available for misonidazole and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.
Topics: Adult; Aged; Cell Hypoxia; Chordoma; Feasibility Studies; Female; Humans; Male; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasm Recurrence, Local; Photons; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Proton Therapy; Radiopharmaceuticals; Radiotherapy Dosage; Relative Biological Effectiveness; Sacrococcygeal Region; Spinal Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.
Topics: Adult; Cell Hypoxia; Chordoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Skull Base Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorine Radioisotopes; Germany; Head and Neck Neoplasms; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2005 |
Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
Topics: Adult; Aged; Brain Neoplasms; Clinical Trials as Topic; Esophageal Neoplasms; Female; Glioma; Humans; Kinetics; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles | 1981 |
The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Hydroxyurea; Incidence; Lymph Node Excision; Middle Aged; Misonidazole; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Survival Analysis; Thrombocytosis; Uterine Cervical Neoplasms | 2000 |
Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer.
Topics: Adult; Aged; Clinical Trials as Topic; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Prognosis; Radiotherapy; Radiotherapy Dosage; Random Allocation | 1986 |
16 other study(ies) available for misonidazole and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and
Topics: Adult; Aged; Bevacizumab; Biomarkers, Pharmacological; Brain Neoplasms; Cerebral Blood Volume; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Positron-Emission Tomography; Progression-Free Survival; Tumor Hypoxia; Young Adult | 2021 |
Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.
Topics: Adult; Aged; Carcinoma; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Misonidazole; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated | 2017 |
Hypoxic volume evaluated by
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Neck Dissection; Neoplasm Grading; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Treatment Outcome; Tumor Hypoxia | 2018 |
Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Dose-Response Relationship, Radiation; Female; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Mice; Mice, Nude; Misonidazole; Neoplasm Recurrence, Local; Radiation-Sensitizing Agents; Radionuclide Imaging; Radiopharmaceuticals; Random Allocation; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2014 |
The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Coloring Agents; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heterografts; Mice; Mice, Nude; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2015 |
Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
Topics: Adult; Aged; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2016 |
The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology.
Topics: Adult; Aged; Drug Evaluation; Female; Genital Neoplasms, Female; Humans; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Oxygen; Palliative Care; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents | 1984 |
Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma.
Topics: Adult; Aged; Brachytherapy; Electrons; Female; Humans; Intraoperative Period; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Palliative Care; Pancreatic Neoplasms; Radiation, Ionizing | 1984 |
[Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Dexamethasone; Drug Interactions; Esophageal Neoplasms; Exanthema; Female; Glioma; Half-Life; Humans; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Phenytoin | 1981 |
The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02).
Topics: Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Nausea; Neoplasm Recurrence, Local; Neoplasm Staging; Nitroimidazoles; Paresthesia; Pharyngeal Neoplasms; Prognosis | 1981 |
Perturbation of the growth kinetics of C3H mouse mammary carcinoma by irradiation of tumour and host and by attempted pre-immunization of host.
Topics: Adenocarcinoma; Animals; Dose-Response Relationship, Radiation; Immunization; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Recurrence, Local; Neoplasm Transplantation; Time Factors; Transplantation, Homologous | 1980 |
Regression, recurrence and cure in an irradiated mouse tumour.
Topics: Animals; Dose-Response Relationship, Radiation; Female; Male; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Recurrence, Local; Neoplasms; Time Factors | 1979 |
Palliative topical and systemic misonidazole with low-dose irradiation for recurrent carcinoma of the cervix uteri.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Misonidazole; Neoplasm Recurrence, Local; Palliative Care; Radiotherapy Dosage; Uterine Cervical Neoplasms | 1986 |
Misonidazole and CCNU chemotherapy for recurrent primary brain tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Glioblastoma; Glioma; Humans; Lomustine; Middle Aged; Misonidazole; Neoplasm Recurrence, Local | 1987 |
Interstitial misonidazole: clinical experience in advanced mouth cancer.
Topics: Animals; Carcinoma, Squamous Cell; Drug Implants; Humans; Misonidazole; Mouth Neoplasms; Needles; Neoplasm Recurrence, Local; Swine | 1988 |
Retreatment of pediatric brain tumors with radiation and misonidazole. Results of a CCSG/RTOG phase I/II study.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Ependymoma; Female; Humans; Male; Medulloblastoma; Misonidazole; Neoplasm Recurrence, Local; Oligodendroglioma; Prognosis | 1986 |